{"id":"idp-120-vehicle-gel","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"IDp-120 Vehicle Gel is a topical formulation intended to deliver immunomodulatory activity through a gel vehicle. The exact molecular mechanism and active pharmaceutical ingredient are not publicly disclosed in detail, but the product is being developed for dermatological indications where local immune stimulation may provide therapeutic benefit.","oneSentence":"IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:14.015Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dermatological conditions (specific indication under investigation in Phase 3)"}]},"trialDetails":[{"nctId":"NCT03664739","phase":"PHASE3","title":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2018-12-05","conditions":"Acne Vulgaris","enrollment":608},{"nctId":"NCT03664752","phase":"PHASE3","title":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2018-12-10","conditions":"Acne Vulgaris","enrollment":585},{"nctId":"NCT03003247","phase":"PHASE2","title":"Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2015-11","conditions":"Acne Vulgaris","enrollment":364},{"nctId":"NCT02537483","phase":"PHASE2","title":"A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris","status":"UNKNOWN","sponsor":"Valeant Pharmaceuticals","startDate":"2015-10","conditions":"Acne Vulgaris","enrollment":350}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":130,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IDp-120 Vehicle Gel","genericName":"IDp-120 Vehicle Gel","companyName":"Bausch Health Americas, Inc.","companyId":"bausch-health-americas-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site. Used for Dermatological conditions (specific indication under investigation in Phase 3).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}